[R01] DIAN-TU: Tau Next Generation Prevention Trial
Ente: National Institute on Aging
Scadenza: 2027-05-31
Importo max: $16,532,036
Paese: US
Descrizione
PROJECT SUMMARY
The DIAN-TU platform was formed to design and manage interventional therapeutic trials and find a treatment that provides cognitive benefit for those certain to develop dominantly inherited AD (DIAD). The DIAN-TU trial platform is now fully operational in 13 countries and 37 sites. T
Settori: National Institute on Aging
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.